Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 6/2014

01-06-2014 | Original Paper

Caregivers’ Intentions to Disclose HIV Diagnosis to Children Living with HIV in South Africa: A Theory-Based Approach

Authors: John B. Jemmott III, G. Anita Heeren, Lulama Sidloyi, C. Show Marange, Joanne C. Tyler, Zolani Ngwane

Published in: AIDS and Behavior | Issue 6/2014

Login to get access

Abstract

When children know their HIV serostatus, they are more likely to cooperate with steps to manage their health and the risk of transmitting HIV to others. Mounting evidence indicates that caregivers often do not disclose to HIV-positive children that the children are living with HIV, but little is known about the modifiable determinants of pediatric HIV disclosure. The present study examined theory-of-planned-behavior predictors of the intention to disclose to children their HIV diagnosis. The participants were 100 caregivers of HIV-positive children in Eastern Cape Province, South Africa. Proportional-odds logistic regression analysis revealed that normative support for disclosure and caregiver-child communication predicted the intention to disclose, whereas behavioral beliefs regarding the consequences of disclosing and self-efficacy to disclose did not. The results suggest that interventions to increase pediatric HIV disclosure in South Africa should help caregivers enlist support for disclosure among important referents and improve communication with their HIV-infected children.
Literature
1.
2.
Shisana O, Rehle T, Simbayi LC, et al. South African national HIV prevalence, incidence, behaviour and communication survey, 2008. Cape Town: HSRC Press; 2009.
3.
4.
Martinson NA, Moultrie H, van Niekerk R, et al. HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort. Int J Tuberc Lung Dis. 2009;13(7):862–7.PubMed
5.
Sutcliffe CG, van Dijk JH, Bolton C, et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;8(8):477–89.PubMedCrossRef
6.
Blasini I, Chantry C, Cruz C, et al. Disclosure model for pediatric patients living with HIV in Puerto Rico: design, implementation, and evaluation. J Dev Behav Pediatr. 2004;25(3):181–9.PubMedCrossRef
7.
Kallem S, Renner L, Ghebremichael M, et al. Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana. AIDS Behav. 2011;15(6):1121–7.PubMedCentralPubMedCrossRef
8.
Lesch A, Swartz L, Kagee A, et al. Paediatric HIV/AIDS disclosure: towards a developmental and process-oriented approach. AIDS Care. 2007;19(6):811–6.PubMedCrossRef
9.
Crepaz N, Marks G. Towards an understanding of sexual risk behavior in people living with HIV: a review of social, psychological, and medical findings. Aids. 2002;16:135–49.PubMedCrossRef
10.
Bikaako-Kajura W, Luyirika E, Purcell DW, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav. 2006;10(4 Suppl):S85–93.PubMedCrossRef
11.
Santamaria EK, Dolezal C, Marhefka SL, et al. Psychosocial implications of HIV serostatus disclosure to youth with perinatally acquired HIV. AIDS Patient Care STDS. 2011;25(4):257–64.PubMedCentralPubMedCrossRef
12.
Wiener L, Mellins CA, Marhefka S, et al. Disclosure of an HIV diagnosis to children: history, current research, and future directions. J Dev Behav Pediatr. 2007;28(2):155–66.PubMedCentralPubMedCrossRef
13.
Heeren GA. Changing methods of disclosure. Literature review of disclosure to children with terminal illness, including HIV. Innov Eur J Soc Sci Res. 2011;24(1–2):199–208.CrossRef
14.
Brown BJ, Oladokun RE, Osinusi K, et al. Disclosure of HIV status to infected children in a Nigerian HIV Care Programme. AIDS Care. 2011;23(9):1053–8.PubMedCrossRef
15.
Menon A, Glazebrook C, Campain N, et al. Mental health and disclosure of HIV status in Zambian adolescents with HIV infection: implications for peer-support programs. J Acquir Immune Defic Syndr. 2007;46(3):349–54.PubMedCrossRef
16.
Moodley K, Myer L, Michaels D, et al. Paediatric HIV disclosure in South Africa—caregivers’ perspectives on discussing HIV with infected children. S Afr Med J. 2006;96(3):201–4.PubMed
17.
Vaz LM, Maman S, Eng E, et al. Patterns of disclosure of HIV status to infected children in a sub-Saharan African setting. J Dev Behav Pediatr. 2011;32(4):307–15.PubMedCentralPubMedCrossRef
18.
Abebe W, Teferra S. Disclosure of diagnosis by parents and caregivers to children infected with HIV: prevalence associated factors and perceived barriers in Addis Ababa. Ethiopia AIDS Care. 2012;24(9):1097–102.CrossRef
19.
Kouyoumdjian FG, Meyers T, Mtshizana S. Barriers to disclosure to children with HIV. J Trop Pediatr. 2005;51(5):285–7.PubMedCrossRef
20.
John-Stewart GC, Wariua G, Beima-Sofie KM, et al. Prevalence, perceptions, and correlates of pediatric HIV disclosure in an HIV treatment program in Kenya. AIDS Care. 2013;25(9):1067–76.PubMedCrossRef
21.
Oberdorfer P, Puthanakit T, Louthrenoo O, et al. Disclosure of HIV/AIDS diagnosis to HIV-infected children in Thailand. J Paediatr Child Health. 2006;42(5):283–8.PubMedCrossRef
22.
Funck-Brentano I, Costagliola D, Seibel N, et al. Patterns of disclosure and perceptions of the human immunodeficiency virus in infected elementary school-age children. Arch Pediatr Adolesc Med. 1997;151(10):978–85.PubMedCrossRef
23.
Heeren GA, Jemmott JB 3rd, Sidloyi L, et al. Disclosure of HIV diagnosis to HIV-infected children in South Africa: focus groups for intervention development. Vulnerable Child Youth Stud. 2012;7(1):47–54.PubMedCentralPubMedCrossRef
24.
Wiener LS, Battles HB, Heilman N, et al. Factors associated with disclosure of diagnosis to children with HIV/AIDS. Pediatr AIDS HIV Infect. 1996;7(5):310–24.PubMed
25.
Vaz L, Corneli A, Dulyx J, et al. The process of HIV status disclosure to HIV-positive youth in Kinshasa, Democratic Republic of the Congo. AIDS Care. 2008;20(7):842–52.PubMedCrossRef
26.
Qiao S, Li X, Stanton B. Disclosure of parental HIV Infection to children: a systematic review of global literature. AIDS Behav. 2013;17(1):369–89.
27.
Mellins CA, Brackis-Cott E, Dolezal C, et al. Patterns of status disclosure to perinatally HIV-infected children and subsequent mental health outcomes. Clin Child Psychol Psychiatr. 2002;7(1):101–14.CrossRef
28.
Jemmott LS, Jemmott JB, 3rd, Ngwane Z, et al. “Let Us Protect Our Future!” A culturally congruent evidenced-based HIV/STD risk-reduction intervention for young South African adolescents. Health Educ Res 2013. doi:10.​1093/​her/​cyt072.
29.
Jemmott JB 3rd. The reasoned action approach in HIV risk-reduction strategies for adolescents. Ann Am Acad Polit Soc Sci. 2012;640:150–72.CrossRef
30.
Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211.CrossRef
31.
Fishbein M, Ajzen I. Predicting and changing behavior: the reasoned action approach. New York: Taylor and Francis Group; 2010.
32.
Albarracin D, Johnson BT, Fishbein M, et al. Theories of reasoned action and planned behavior as models of condom use: a meta-analysis. Psychol Bull. 2001;127(1):142–61.PubMedCrossRef
33.
Armitage CJ, Conner M. Efficacy of the theory of planned behaviour: a meta-analytic review. Br J Soc Psychol. 2001;40(Pt 4):471–99.PubMedCrossRef
34.
Heeren GA, Jemmott JB 3rd, Mandeya A, et al. Sub-Saharan African university students’ beliefs about condoms, condom-use intention, and subsequent condom use: a prospective study. AIDS Behav. 2009;13(2):268–76.PubMedCrossRef
35.
Heeren GA, Jemmott JB 3rd, Ngwane Z, et al. A randomized controlled pilot study of an HIV risk-reduction intervention for sub-Saharan African university students. AIDS Behav. 2013;17(3):1105–15.PubMedCentralPubMedCrossRef
36.
Bandura A. Social foundations of thought and action: a social cognitive theory. Englewood Cliffs: Prentice-Hall; 1986.
37.
Bandura A. Self-efficacy: the exercise of control. New York: W. H. Freeman and Company; 1997.
38.
39.
Webb TL, Sheeran P. Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychol Bull. 2006;132(2):249–68.PubMedCrossRef
40.
Heeren GA, Jemmott JB III, Mandeya A, et al. Theory-based predictors of condom use among university students in the United States and South Africa. AIDS Educ Prev. 2007;19(1):1–12.PubMedCrossRef
41.
Statistics South Africa. The South African National Census of 2001. Pretoria: Statistics South Africa; 2001.
42.
Ford CA, Millstein SG, Halpern-Felsher BL, et al. Influence of physician confidentiality assurances on adolescents’ willingness to disclose information and seek future health care. A randomized controlled trial. JAMA. 1997;278(12):1029–34.PubMedCrossRef
43.
Thrall JS, McCloskey L, Ettner SL, et al. Confidentiality and adolescents’ use of providers for health information and for pelvic examinations. Arch Pediatr Adolesc Med. 2000;154(9):885–92.PubMedCrossRef
44.
Turner C, Miller H, Rogers S. Survey measurement of sexual behavior: problems and progress. In: Bancroft J, editor. Researching sexual behavior: methodological issues. Bloomington: Indiana University Press; 1997. p. 237–60.
45.
Hutchinson MK. The Parent-Teen Sexual Risk Communication Scale (PTRSRC-III). Instrument development and psychometrics. Nurs Res. 2007;56(1):1–8.PubMedCrossRef
46.
Triandis HC, McCusker C, Hui CH. Multimethod probes of individualism and collectivism. J Pers Soc Psychol. 1990;59(5):1006–20.CrossRef
47.
Carnevale J, Gropper AB, Agnew-Blais J, et al. Knowledge base and caretaker-child communication about HIV in peri-urban schoolchildren of Lusaka Zambia. AIDS Care. 2011;23(5):646–53.PubMedCrossRef
48.
Babalola S, Tambashe BO, Vondrasek C. Parental factors and sexual risk-taking among young people in Cote d’Ivoire. Afr J Reprod Health. 2005;9(1):49–65.PubMedCrossRef
49.
Bell CC, Bhana A, Petersen I, et al. Building protective factors to offset sexually risky behaviors among black youths: a randomized control trial. J Natl Med Assoc. 2008;100(8):936–44.PubMedCentralPubMed
50.
Bhana A, McKay MM, Mellins C, et al. Family-based HIV prevention and intervention services for youth living in poverty-affected contexts: the CHAMP model of collaborative, evidence-informed programme development. J Int AIDS Soc. 2010;13(Suppl 2):S8.PubMedCentralPubMedCrossRef
51.
Phetla G, Busza J, Hargreaves JR, et al. “They have opened our mouths”: increasing women’s skills and motivation for sexual communication with young people in rural South Africa. AIDS Educ Prev. 2008;20(6):504–18.PubMedCentralPubMedCrossRef
52.
Biadgilign S, Deribew A, Amberbir A, et al. Factors associated with HIV/AIDS diagnostic disclosure to HIV infected children receiving HAART: a multi-center study in Addis Ababa, Ethiopia. PLoS One. 2011;6(3):e17572.PubMedCentralPubMedCrossRef
53.
54.
Jemmott JB 3rd, Jemmott LS, O’Leary A, et al. School-based randomized controlled trial of an HIV/STD risk-reduction intervention for South African adolescents. Arch Pediatr Adolesc Med. 2010;164(10):923–9.PubMedCrossRef
55.
Jemmott III JB, Jemmott LS, O’Leary A, et al. Efficacy of an HIV risk-reduction intervention over 54 months: a school-based randomized controlled trial with young South African Adolescents: University of Pennsylvania Perelman School of Medicine. 2013.
56.
Myer L, Moodley K, Hendricks F, et al. Healthcare providers’ perspectives on discussing HIV status with infected children. J Trop Pediatr. 2006;52(4):293–5.PubMedCrossRef
57.
Butler AM, Williams PL, Howland LC, et al. Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection. Pediatrics. 2009;123(3):935–43.PubMedCentralPubMedCrossRef
58.
Ferris M, Burau K, Schweitzer AM, et al. The influence of disclosure of HIV diagnosis on time to disease progression in a cohort of Romanian children and teens. AIDS Care. 2007;19(9):1088–94.PubMedCrossRef
Metadata
Title
Caregivers’ Intentions to Disclose HIV Diagnosis to Children Living with HIV in South Africa: A Theory-Based Approach
Authors
John B. Jemmott III
G. Anita Heeren
Lulama Sidloyi
C. Show Marange
Joanne C. Tyler
Zolani Ngwane
Publication date
01-06-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0672-0

Other articles of this Issue 6/2014

AIDS and Behavior 6/2014 Go to the issue

Original Paper

Feasibility, Safety, Acceptability, and Preliminary Efficacy of Measurement-Based Care Depression Treatment for HIV Patients in Bamenda, Cameroon

Original Paper

Longitudinal Characterization of Depression and Mood States Beginning in Primary HIV Infection

Original Paper

Perceived Mental Health Status of Drug Users with HIV: Concordance Between Caregivers and Care Recipient Reports and Associations with Caregiving Burden and Reciprocity

Original Paper

Depressive Symptoms and Antiretroviral Therapy (ART) Initiation Among HIV-Infected Russian Drinkers

Original Paper

Do HIV-Positive Women Receive Depression Treatment that Meets Best Practice Guidelines?

Original Paper

First Evaluation of a Population-Based Screen to Detect Emotional-Behavior Disorders in Orphaned Children in Sub-Saharan Africa
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits